MediciNova Announces Development Progress on Intranasal Formulation of SARS-CoV-2 Vaccine for COVID-19

    NEXT STORY
    Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222
    PREV STORY
    Medical Practice Income, Inc., a Subsidiary of USA Equities Corp. (USAQ), Announces the Early Success of QHSLab Launch in South Florida
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

    author_avatar
    NASDAQ Market News

    OncoMed Provides Update on Tarextumab Phase 2 Pancreatic Cancer ALPINE Trial

    REDWOOD CITY, Calif., Jan. 25, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a ...

    author_avatar
    NASDAQ Market News

    Roche submits supplemental biologics license application to US FDA for Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment

    Roche's application is being reviewed under the US FDA's Real-Time Oncology Review and Assessment ...

    author_avatar
    NASDAQ Market News